Fig. 2.

Effect of rosiglitazone on activation of mTOR in balloon-injured OLETF rats. After exposure of the left carotid artery to a 2F Fogarty balloon catheter, the expresson of p-mTOR was detected through immunostaining of sections of tissue cut through the areas of balloon injury after treatment of 3 mg/kg of rosiglitazone. The immunostain was visualized with Texas Red-conjugated goat anti-rabbit IgG secondary antibody. mTOR, mammalian target of rapamycin; OLETF, Otsuka Long-Evans Tokushima Fatty. ^*p < 0.05, ^†p < 0.01.